Comprehensive Cardio-screening Panel
The "Comprehensive Cardio Screening" panel is a comprehensive laboratory assessment of a patient’s cardiometabolic profile aimed at the early detection of factors that may lead to myocardial infarction, stroke, and atherosclerosis. It is not merely a set of laboratory tests, but a tool for clinical decision-making and risk management.
The panel combines key biomarkers reflecting lipid metabolism, inflammatory processes, vascular wall status, and metabolic disorders. Unlike basic laboratory testing, this profile makes it possible not only to identify current abnormalities but also to predict the likelihood of future cardiovascular events.
From a practical perspective, the panel addresses several objectives:
- stratification of individual cardiovascular risk;
- detection of hidden abnormalities that have not yet manifested clinically;
- determination of preventive strategies (lifestyle modification, pharmacological correction);
- monitoring the effectiveness of therapy (including statins and other medications);
- development of a personalized patient management strategy.
The panel is particularly relevant for patients with risk factors such as arterial hypertension, diabetes mellitus, excess body weight, smoking, a sedentary lifestyle, chronic stress, as well as a family history of cardiovascular disease.
The key advantage is the ability to identify the risk before it develops into an actual cardiovascular event. In clinical practice, this means shifting from reactive to proactive medicine: rather than treating consequences, the focus is on managing their underlying causes.
By scanning the QR code, you can:
- calculate your individual 10-year risk of cardiovascular events;
- visualize your risk level (low, moderate, high, or very high);
- obtain guidance on target lipid levels;
- understand how far your current results deviate from a safe profile.